Seranova

Seranova Bio is a biotechnology company developing therapeutics from naturally occurring protective autoantibodies. Its REAP platform profiles these antibodies and links their activity to clinical outcomes, helping identify human-supported therapeutic targets and understand disease biology. The company applies this approach to drug discovery across areas including autoimmunity, oncology, and neurodegeneration, with the goal of advancing first-in-class therapies inspired by patient biology.